← Back to Search

Pediatric Boot Camp Program for Childhood Type 1 Diabetes

N/A
Recruiting
Research Sponsored by Georgetown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Duration of type 1 diabetes >1 year
Age 11-18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial tests a new, more intensive program to see if it can better control blood sugar in children with type 1 diabetes.

Who is the study for?
This trial is for children aged 11-18 with type 1 diabetes who have had it for over a year and struggle to control their blood sugar (HbA1c > 8.5%). They must use Dexcom, have a phone compatible with the InPen app and Dexcom Clarity app, and be able to attend telehealth visits.Check my eligibility
What is being tested?
The program being tested is an intensive 13-week course using telehealth visits designed to help these kids better manage their glucose levels through remote guidance and monitoring.See study design
What are the potential side effects?
Since this trial involves educational interventions rather than medication, there are no direct medical side effects. However, participants may experience stress or frustration related to technology use or lifestyle changes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had type 1 diabetes for more than a year.
Select...
I am between 11 and 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in HbA1c

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: intensive monitoringExperimental Treatment1 Intervention
intensive monitoring every week will be given to participants
Group II: standard of careActive Control1 Intervention
standard of care will be given as per usual care

Find a Location

Who is running the clinical trial?

Georgetown UniversityLead Sponsor
343 Previous Clinical Trials
136,470 Total Patients Enrolled

Media Library

Pediatric Boot Camp Program Clinical Trial Eligibility Overview. Trial Name: NCT05066893 — N/A
Type 1 Diabetes Research Study Groups: standard of care, intensive monitoring
Type 1 Diabetes Clinical Trial 2023: Pediatric Boot Camp Program Highlights & Side Effects. Trial Name: NCT05066893 — N/A
Pediatric Boot Camp Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05066893 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research project have any open slots available?

"Affirmative. Clinicaltrials.gov provides evidence that this trial, which was initially launched on November 5th 2020 and last updated September 23rd 2021, is recruiting individuals to participate in the study at 1 location with 32 participants needed overall."

Answered by AI

Does this research permit those of legal age to partake?

"To meet the requirements of this clinical trial, enrollees must be between 11 and 18 years old. There are 198 similar trials for minors and 182 trials recruiting adults over 65."

Answered by AI

Are there any criteria that prospective participants must meet to join this trial?

"This study is currently admitting 32 minors, ranging from 11 to 18 years old of age, who have a progeny. Furthermore, these applicants are required to meet certain additional conditions: HbA1c > 8.5%, at least one year with type 1 diabetes diagnosis and compatibility between their phone and the InPen app plus Dexcom Clarity app.."

Answered by AI

What is the accepted capacity of participants for this scientific trial?

"Affirmative. Clinicaltrials.gov attests that the study, which was initially published on November 5th 2020, is recruiting participants at this time. The medical trial seeks to enrol 32 individuals from a single site."

Answered by AI
~7 spots leftby Apr 2025